# Prostate Boost Irradiation With Stereotactic Body RT (SBRT)

> **NCT03380806** · PHASE2 · UNKNOWN · sponsor: **Juravinski Cancer Center** · enrollment: 100 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** LHRH agonist
- **RADIATION:** Pelvic Radiation
- **RADIATION:** Stereotactic Body Radiotherapy (SBRT)
- **RADIATION:** Conventional Radiotherapy (CRT) Prostate Boost

## Key facts

- **NCT ID:** NCT03380806
- **Lead sponsor:** Juravinski Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-01
- **Primary completion:** 2022-01-01
- **Final completion:** 2022-01-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-06-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03380806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03380806, "Prostate Boost Irradiation With Stereotactic Body RT (SBRT)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03380806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*